	Perioperative enfortumab vedotin-pembrolizumab, gemcitabine-cisplatin-durvalumab, and dose-dense MVAC in cisplatin-eligible muscle-invasive bladder cancer: A benefit-risk Bayesian network meta-analysis. Urol Oncol Subiela JD, González-Padilla DA, Scilipoti P, Slusarczyk A, Pichler R, Guerrero-Ramos F, Artiles-Medina A, Caño-Velasco J, Aumatell J, Krajewski W, Mertens LS, Teoh JY, Contieri R, Maiorano BA, Claps F, Del Giudice F, D'Andrea D, Gajate P, Guerrero P, Gallioli A, Villacampa F, Acosta EA, Lozano F, Carrion A, Afferi L, Crespo L, Marcq G, Soria F, Moschini M, Grobet-Jeandin E, Albisinni S, Alvarez-Maestro M, San-José Manso L, Gomez Dos Santos V, Roupret M, Burgos Revilla FJ, Pradere B, Buisan O, Young Academic Urologist (YAU) Urothelial Carcinoma Working Group. PMID: 42881094 [PubMed - as supplied by publisher]
	Radiomics features of diffusion kurtosis imaging and dynamic contrast enhanced-MRI for predicting aggressive pathological characteristics of oral and oropharyngeal squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Yang L, Han R, Aili A, Wu X, Su Y, Wang Y, Shi G, Yang L, Yang L, Duan X, Zhang F. PMID: 42881063 [PubMed - as supplied by publisher]
	Clinical T staging accuracy and its prognostic relevance in oral squamous cell carcinoma. Int J Oral Maxillofac Surg Richter M, Vertic V, Mödl L, Sprünken E, Doll C, Heiland M, Koerdt S, Mrosk F. PMID: 42881028 [PubMed - as supplied by publisher]
	Pre-existing low back and joint pain is associated with locomotive syndrome deterioration in cancer patients following primary tumor resection: A prospective study. J Orthop Sci Sato K, Imanishi J, Hirahata M, Ogata N, Iimuro S, Fujita R, Yasui Y, Matsuyama T, Kawano H. PMID: 42881001 [PubMed - as supplied by publisher]
	B7H3-Targeted Molecular Imaging for Highly Specific Diagnosis and InÂ Vivo Noninvasive Detection of B7H3 in Breast Cancer. J Nucl Med Xia L, Gong Y, He C, Mei B, Zhang Y, Zhou N, Meng X, Zhu H, Li N, Song G, Yang Z. PMID: 42880960 [PubMed - as supplied by publisher]
	Feasibility of Laparoscopic Partial Cystectomy for Bladder Paraganglioma: A Four-Case Series. Asian J Endosc Surg Sato T, Hayata N, Miura T, Mishina M, Kitamura T, Tsuiki M, Hijikata Y, Kuwahara R, Kasahara S, Moriyoshi K, Kanno T. PMID: 42880937 [PubMed - indexed for MEDLINE]
	Epigenetic personalized medicine in glioblastoma. Handb Clin Neurol Romani M. PMID: 42880852 [PubMed - indexed for MEDLINE]
	Developing a shared decision-making intervention to support choices about prophylactic cranial irradiation treatment for small-cell lung cancer: a study protocol. BMJ Open Dixon K, Aznar M, Bekker H, Burke TO, Dempsey C, Halkyard E, Horne A, Faivre-Finn C. PMID: 42880798 [PubMed - in process]
	Return to work and work abandonment in female breast cancer survivors: systematic review and meta-analysis protocol. BMJ Open Vanzo AAF, Gutierres IG, Xavier-Neto AG, Laperche-Santos D, Resende H, Mendes GO, Oliveira SCS, Araujo ML, Medeiros KS, Cunha AACCD, Assad-Suzuki D. PMID: 42880796 [PubMed - in process]
	Intrapancreatic Fat Deposition and Prostate Cancer Risk: A Primary Case-Control Study. Technol Cancer Res Treat Wang H, Li H, Zhang K, Wu L, Wang C, Fang D, Yu Y, Yang X, Sun S, Chen X, Bi S, Wen H. PMID: 42880771 [PubMed - indexed for MEDLINE]
	Cancer as a function of gender. Gac Med Mex Gerson-Cwilich R, Verástegui-Avilés EL. PMID: 42880734 [PubMed - indexed for MEDLINE]
	Pathophysiology, Workup and Treatment of Cancer-Related Ischaemic Stroke. Clin Med (Lond) Patel S, Sengupta S, Feng W, Ryan D. PMID: 42880717 [PubMed - as supplied by publisher]
	Gastric and oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Al-Batran SE, Bencivenga M, Crosby T, Dinis-Ribeiro M, Huguet F, Lordick F, Lorenzen S, Ciarpaglini CM, Obermannova RL, Piessen G, Shitara K, Smyth E, van Grieken NCT, Zaanan A, Ducreux M, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. PMID: 42880714 [PubMed - as supplied by publisher]
	Ocular Immune Toxicity in Cancer Immunotherapy, From Immune Privilege Breakdown to Treatment Rechallenge: A Review. Transl Res Chen KY, Chan HC, Lim M, Chan CM. PMID: 42880691 [PubMed - as supplied by publisher]
	Host restriction factors in HBV-related liver disease and hepatocellular carcinoma: mechanisms of viral-host interplay and implications for therapy. Cell Mol Gastroenterol Hepatol Li Z, Qiu Y, Luedde T, Bock HH, Münk C. PMID: 42880633 [PubMed - as supplied by publisher]
	Dynamic changes in the metabolic network and signalling pathways of cancer stem cells in therapy resistance. Biochim Biophys Acta Rev Cancer Didamson OC, George S, Abrahamse H. PMID: 42880611 [PubMed - as supplied by publisher]
	Identification and functional validation of GREM2 and PIK3C2G as senescence-associated genes in esophageal squamous cell carcinoma. Biochim Biophys Acta Gen Subj Zhao W, Zhao S, Wang C, Dong G, Cui F, Wang M, Lin Z. PMID: 42880610 [PubMed - as supplied by publisher]
	Pilot Study of Timely Integration of Interventional Pain Management for Advanced Cancer. J Pain Symptom Manage Wilson JM, Van Wieren I, Topiwala PS, Ross EL, Gorra M, Wright AA, Hassett M, Yong RJ, Gao R, Ferrick M, Gorman D, Lally K, Jamison RN, Enzinger AC. PMID: 42880515 [PubMed - as supplied by publisher]
	Japanese-style dietary patterns, mortality, and selected cancer outcomes in Japanese populations: a systematic review integrating meta-analysis, food-group loading visualization, and qualitative synthesis. Adv Nutr Yu T, Yamagishi M, Okoshi K, Nomura S, Yamamoto N, Tsugane S. PMID: 42880456 [PubMed - as supplied by publisher]
	Cost-Effectiveness of Telisotuzumab Vedotin-tllv for Previously Treated High c-Met Protein-Overexpressing Nonsquamous Non-Small Cell Lung Cancer in the United States. Value Health Weiss GJ. PMID: 42880447 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1981255

Page 1 of 99063



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy